A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

Viatris

Status and phase: Completed; Phase 4

Conditions: Dyslipidemias

Treatments: Drug: Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00644709

A2581112

Details and patient eligibility

About

A study of the long-term (1 year) effectiveness of atorvastatin to keep patients of high cardiovascular risk at the LDL cholesterol goal of <115 mg/dL

Enrollment: 196 patients

Sex: All

Ages: 30 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Completion of base study
• Dyslipidemia and at high risk of CHD

Exclusion criteria

• Impaired liver function
• Gastrointestinal disease that could limit drug absorption

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

196 participants in 1 patient group

Arm A

Experimental group

Treatment:

Drug: Atorvastatin